Bioavailability (AUC %) |
||||||
---|---|---|---|---|---|---|
Study | N | Drug (mg) | Duration (d) | POS (mg) | POS | Concomitant Drug |
1 | 12 | Cimetidine (800) | 10 | 200 qd | 61 | ND |
2 | 4 | Cyclosporine (ED) | SS | 200 qd | ND | Doses reduced −14-29% in 3 of 4 |
3 | 12 | Glipizide(10) | 1 | 400 bid | 91 | 118 |
4 | 36 | Phenytoin (200) | 10 | 200 qd | 50 | 115 |
5 | 24 | Rifabutin (300) | 17 | 200 qd | 51 | 172 |
6 | 34 | Tacrolimus (0.05a) | 1 | 400 bid | ND | 458 |
7 | 17 | Zidovudine (600) | SS | 200 qd | ND | 112 |
17 | Lamivudine (300) | SS | 200 qd | ND | 107 | |
17 | Ritonavir (1200) | SS | 200 qd | ND | 130 | |
17 | Indinavir (3200) | SS | 200 qd | ND | 116 |
ND = not determined.
mg/kg;